General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced a series of new ...

At the Advances in Genome Biology and Technology, AGBT, General Meeting, 10x Genomics (TXG) announced a series of new product innovations to ...

Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...

Single-cell RNA sequencing has established itself as one ... the performance of Illumina Single Cell with the newest 10X Genomics assay on two different cell types. A live Q&A session will follow ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

Coupled with the invalidation of 10x Genomics’ 10,155,981 patent ... a fundamentally differentiated solution that makes single cell sequencing more scalable without the need for expensive ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

Illumina, Inc. today announced that investors, analysts, and other interested parties can access a live webcast of its upcoming investor session at the AGBT conference.  The investor fireside chat ...

Another initiative is that OWKIN and 10x Genomics have ... reduce the cost and complexity of single-cell multiomics, especially CITE. · On 14 February 2025, Ultima Genomics announced that their UG 100 ...